Literature DB >> 23643524

Modulation of colonic inflammation in Mdr1a(-/-) mice by green tea polyphenols and their effects on the colon transcriptome and proteome.

Matthew P G Barnett1, Janine M Cooney, Yvonne E M Dommels, Katia Nones, Diane T Brewster, Zaneta Park, Christine A Butts, Warren C McNabb, William A Laing, Nicole C Roy.   

Abstract

Animal models are an important tool to understand the complex pathogenesis of inflammatory bowel diseases (IBDs). This study tested the anti-inflammatory potential of a green tea extract rich in polyphenols (GrTP) in the colon of the multidrug resistance targeted mutation (Mdr1a(-/-)) mouse model of IBD. Insights into mechanisms responsible for this reduction in inflammation were gained using transcriptome and proteome analyses. Mice were randomly assigned to an AIN-76A (control) or GrTP-enriched diet. At 21 or 24 weeks of age, a colonic histological injury score was determined for each mouse, colon mRNA transcript levels were assessed using microarrays, and colon protein expression was measured using two-dimensional gel electrophoresis and liquid chromatography-mass spectrometry protein identification. Mean colonic histological injury score of GrTP-fed Mdr1a(-/-) mice was significantly lower compared to those fed the control diet. Microarray and proteomics analyses showed reduced abundance of transcripts and proteins associated with immune and inflammatory response and fibrinogenesis pathways, and increased abundance of those associated with xenobiotic metabolism pathways in response to GrTP, suggesting that its anti-inflammatory activity is mediated by multiple molecular pathways. Peroxisome proliferator-activated receptor-α and signal transducer and activator of transcription 1 appear to be two key molecules which regulate these effects. These results support the view that dietary intake of polyphenols derived from green tea can ameliorate intestinal inflammation in the colon of a mouse model of IBD, and are in agreement with studies suggesting that consumption of green tea may reduce IBD symptoms and therefore play a part in an overall IBD treatment regimen.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigallocatechin gallate (EGCG); Gene expression; Inflammatory bowel diseases; Protein expression

Mesh:

Substances:

Year:  2013        PMID: 23643524     DOI: 10.1016/j.jnutbio.2013.02.007

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  12 in total

Review 1.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

Review 2.  Interactions of tea catechins with intestinal microbiota and their implication for human health.

Authors:  Tongtong Guo; Dan Song; Lu Cheng; Xin Zhang
Journal:  Food Sci Biotechnol       Date:  2019-08-08       Impact factor: 2.391

3.  Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.

Authors:  Beng San Yeoh; Rodrigo Aguilera Olvera; Vishal Singh; Xia Xiao; Mary J Kennett; Bina Joe; Joshua D Lambert; Matam Vijay-Kumar
Journal:  Am J Pathol       Date:  2016-03-08       Impact factor: 4.307

Review 4.  Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases?

Authors:  Lynnette R Ferguson; Matthew P G Barnett
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

Review 5.  Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls.

Authors:  Anouk Kaulmann; Torsten Bohn
Journal:  Oxid Med Cell Longev       Date:  2016-07-10       Impact factor: 6.543

6.  Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption.

Authors:  Xin Yan; Xiaoyun Liu; Yu Wang; Xueyang Ren; Jiamu Ma; Ruolan Song; Xiuhuan Wang; Ying Dong; Qiqi Fan; Jing Wei; Axiang Yu; Hong Sui; Gaimei She
Journal:  Eur J Nutr       Date:  2021-07-02       Impact factor: 5.614

Review 7.  Understanding the Gastrointestinal Protective Effects of Polyphenols using Foodomics-Based Approaches.

Authors:  Wenwen Zhang; Suzhen Qi; Xiaofeng Xue; Yahya Al Naggar; Liming Wu; Kai Wang
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

Review 8.  Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease?

Authors:  Lynnette R Ferguson
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561

9.  Inoculation with enterococci does not affect colon inflammation in the multi-drug resistance 1a-deficient mouse model of IBD.

Authors:  Matthew P G Barnett; Yvonne E M Dommels; Christine A Butts; Shuotun Zhu; Warren C McNabb; Nicole C Roy
Journal:  BMC Gastroenterol       Date:  2016-03-03       Impact factor: 3.067

Review 10.  Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases.

Authors:  Andrea Perrelli; Luca Goitre; Anna Maria Salzano; Andrea Moglia; Andrea Scaloni; Saverio Francesco Retta
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.